These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23205635

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Response to cladribine in patient with systemic mastocytosis.
    Radojković M, Ristić S, Colović N, Terzić T, Colović M.
    Vojnosanit Pregl; 2011 May; 68(5):444-6. PubMed ID: 21739912
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Systemic mastocytosis--rare cause of pathologic vertebral fracture].
    Stamm AC, Burbelko M, Rominger M.
    Rofo; 2008 Jan; 180(1):57-9. PubMed ID: 17968773
    [No Abstract] [Full Text] [Related]

  • 28. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists.
    Johnson GJ, Silvis SE, Roitman B, Blumenthal M, Gilbert HS.
    Am J Gastroenterol; 1980 Dec; 74(6):485-9. PubMed ID: 6782861
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ, Brenn T, Hornick JL.
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Systemic mastocytosis: a potential neurologic emergency.
    Boncoraglio GB, Brucato A, Carriero MR, Maccagnano E, Robbiolo L, Scappatura LO, Soligo D, Parati EA.
    Neurology; 2005 Jul 26; 65(2):332-3. PubMed ID: 16043817
    [No Abstract] [Full Text] [Related]

  • 33. Multiple life-threatening fainting episodes: fatal systemic mastocytosis.
    Confino-Cohen R, Zilber M, Goldberg A.
    Isr Med Assoc J; 2003 Oct 26; 5(10):752-3. PubMed ID: 14719479
    [No Abstract] [Full Text] [Related]

  • 34. [Mastocytosis and diffuse osteoporosis. (Description of a case)].
    Bonzano G.
    Policlinico Med; 1971 Oct 26; 78(6):272-83. PubMed ID: 5157401
    [No Abstract] [Full Text] [Related]

  • 35. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.
    Pardanani A, Tefferi A.
    Curr Opin Hematol; 2010 Mar 26; 17(2):125-32. PubMed ID: 20075725
    [Abstract] [Full Text] [Related]

  • 36. [Multiple fibromas in systemic mastocytosis].
    Klepper L, Tronnier M.
    J Dtsch Dermatol Ges; 2005 May 26; 3(5):363-5. PubMed ID: 16372804
    [Abstract] [Full Text] [Related]

  • 37. Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis.
    Poynard T, Nataf C, Messing B, Modigliani R, Lecompte T, Nicolas P, Dray F, Ferme C.
    N Engl J Med; 1982 Jul 15; 307(3):186. PubMed ID: 6953312
    [No Abstract] [Full Text] [Related]

  • 38. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA, Telizyn S, Ahlstedt S, Olafsson JH, Roupe G, Bienenstock J.
    Clin Invest Med; 1986 Jul 15; 9(1):21-5. PubMed ID: 3955917
    [Abstract] [Full Text] [Related]

  • 39. [Urticaria pigmentosa and systemic mastocytosis].
    Roupe G.
    Lakartidningen; 1989 Apr 12; 86(15):1370-2. PubMed ID: 2716450
    [No Abstract] [Full Text] [Related]

  • 40. Osteoporosis and mastocytosis with late appearance of urticaria pigmentosa.
    Colver GB, Ryan TJ, Dawber RP, Wojnarowska F, Smith R.
    J R Soc Med; 1985 Oct 12; 78(10):866-7. PubMed ID: 4045893
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.